Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer

NCT00022217 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: carboplatin
DRUG: cisplatin-e therapeutic implant
DRUG: paclitaxel

Sponsor

Matrix Pharmaceutical